ISRCTN14530574已完成未知
FARAH study: Fecal trAnsplantation to Reduce therapy-refractory graft versus host disease in Allogeneic Hematopoietic stem cell transplantation
Amsterdam UMC Department of Hematology0 个研究点目标入组 15 人开始时间: 2018年7月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
2020 results in https://doi.org/10.1126/scitranslmed.aaz8926 (added 02/02/2021)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Steroid-refractory or steroid-dependent graft versus host disease of the intestine
- •2. Aged 18 years or older
排除标准
- •1. Unable to provide informed consent
- •The use of immunosuppressive therapy and/or concurrent (systemic) infection does not exclude patients from participation in the study.
研究者
相似试验
已完成
不适用
FARAH study Fecal trAnsplantation to Reduce therapy-refractory graft versus host disease in Allogeneic Hematopoietic stem cell transplantatioNL-OMON44039Academisch Medisch Centrum15
Unknown
不适用
Fecal Transplant for MDRO DecolonizationMulti-antibiotic ResistanceNCT04181112University of British Columbia90
已完成
2 期
Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot StudyHIV-1-infectionNCT06022406Jean-Pierre Routy20
已完成
2 期
FMT and Fiber in Patients With Metabolic SyndromeMetabolic SyndromeObesityNCT03727321University of Alberta68
已完成
4 期
Fecal Microbiota TransplantClostridium Difficile InfectionNCT04090346Methodist Health System24